Elaine R. Peskind
Department of Psychiatry and Behavioral Sciences
University of Washington School of Medicine
VA Northwest Network Mental Illness Research, Education, and Clinical Center
VA Puget Sound Health Care System
Dr. Elaine Peskind is the co-director of the VA VISN 20 Northwest Network Mental Illness Research, Education, and Clinical Center (MIRECC). She is also the Friends of Alzheimer’s Research professor of psychiatry and behavioral sciences at the University of Washington School of Medicine and is the associate director of the UW Alzheimer’s Disease Research Center in Seattle, WA. Her research over the past 35 years has addressed brain stress hormone systems in aging and Alzheimer’s disease (AD), treatment of cognitive and behavioral problems in AD, and cerebrospinal fluid (CSF) biomarkers in AD and related neurodegenerative dementing disorders.
Dr. Peskind is a co-principal investigator of a national multicenter study of prazosin for disruptive agitation in Alzheimer’s disease funded by the Alzheimer’s Disease Cooperative Study. Recently her research has focused on combat trauma posttraumatic stress disorder (PTSD) and the clinical phenomenology as well as neuroimaging and CSF biomarkers of neurodegeneration in combat blast concussion mild traumatic brain injury and in Gulf War Veterans Illness. She continues to conduct single-site and multisite large-scale studies of CSF biomarkers and pharmacological treatment trials for behavioral disorders and traumatic brain injury.
Dr. Peskind has contributed to more than 300 publications and has been continuously funded with VA Merit Review or National Institutes of Health R01 grants for over 20 years. She is the principal investigator of both the NIA T32 training grant “Neurobehavior, Neuropathology, and Risk Factors in Alzheimer’s Disease” and the MIRECC Advanced Research Fellowship. She is an elected fellow of the American College of Neuropsychopharmacology. In 2018, Dr. Peskind was selected as the recipient of the Paul B. Magnuson Award, Veterans Affairs Rehabilitation Research and Development’s highest award for outstanding research in neurodegenerative disorders, PTSD, and traumatic brain injury.